# Janssen Biotech Inc. – FDA Inspection, Apr 14, 2011

Source: https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/b5041907-852a-4c3f-9afb-b7f50fe7a765
Source feed: FDA_Inspections

> FDA inspection 717037 of Janssen Biotech Inc., April 14, 2011. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 717037
- Company Name: Janssen Biotech Inc.
- Inspection Date: 2011-04-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1255317 - 2025-01-17
- FDA Inspection 1251380 - 2024-09-24
- FDA Inspection 1057464 - 2018-06-22
- [FDA Inspection 963728 - 2016-02-25](https://www.keypedia.com/records/fda_inspections/janssen-biotech-inc/8e061774-afc5-45ac-b472-4e76bf3ee237)
- FDA Inspection 954726 - 2015-11-24

Company: https://www.keypedia.com/companies/janssen-biotech-inc/6e8c48fd-0d40-45bb-8c8e-4d8eff6b5a0c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
